Skip to main content

and
  1. Article

    Open Access

    Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study

    Patients diagnosed with low-risk prostate cancer (PCa) are confronted with a difficult decision regarding whether to undergo definitive treatment or to pursue an active surveillance protocol. This is potential...

    Alice Guan, Eduardo J. Santiago-Rodríguez, Benjamin I. Chung, Janet K. Shim in BMC Cancer (2023)

  2. No Access

    Article

    Are associations between obesity and prostate cancer outcomes following radical prostatectomy the same in smokers and non-smokers? Results from the SEARCH Cohort

    Obesity and smoking have been associated with poor prostate cancer (PC) outcomes. We investigated associations between obesity and biochemical recurrence (BCR), metastasis, castrate resistant-PC (CRPC), PC-spe...

    Ivy T. Liu, Lin Gu, Amanda M. De Hoedt, Matthew R. Cooperberg in Cancer Causes & Control (2023)

  3. No Access

    Article

    Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formula

    As with many chronic illnesses, recurrent prostate cancer generally requires sustained treatment to prolong survival. However, initiating treatment immediately after recurrence may negatively impact quality of...

    Louisa H. Smith, Xabier García-Albéniz, June M. Chan in European Journal of Epidemiology (2022)

  4. No Access

    Article

    Monocyte counts and prostate cancer outcomes in white and black men: results from the SEARCH database

    Circulating inflammatory markers may predict prostate cancer (PC) outcomes. For example, a recent study showed that higher peripheral blood monocyte counts were associated with aggressive PC in Asian men under...

    Azeb Yirga, Taofik Oyekunle, Lauren E. Howard in Cancer Causes & Control (2021)

  5. No Access

    Article

    First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH

    We aimed to study the associations between androgen-deprivation therapy (ADT)-induced weight changes and prostate cancer (PC) progression and mortality in men who had undergone radical prostatectomy (RP).

    Kagan Griffin, Ilona Csizmadi, Lauren E. Howard in Cancer Causes & Control (2019)

  6. No Access

    Article

    Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database

    Systemic inflammation, as measured by C-reactive protein, has been linked with poor prostate cancer (PC) outcomes, predominantly in white men. Whether other immune measures like white blood cell counts are cor...

    Adriana C. Vidal, Lauren E. Howard, Amanda de Hoedt in Cancer Causes & Control (2018)

  7. No Access

    Chapter

    Prostate Cancer Markers

    Diagnostic biomarkers derived from blood, urine, or prostate tissue provide additional information beyond clinical calculators to determine the risk of detecting high-grade prostate cancer. Once diagnosed, m...

    Adam J. Gadzinski, Matthew R. Cooperberg in Genitourinary Cancers (2018)

  8. Article

    Epidemiology of prostate cancer

    Matthew R. Cooperberg, June M. Chan in World Journal of Urology (2017)

  9. No Access

    Article

    Clinical Utility of Biomarkers in Localized Prostate Cancer

    A new generation of prostate cancer (PCa) biomarkers has emerged, including diagnostic serum and urine markers aimed at refining the identification high-grade tumors and tissue-based gene expression assays off...

    Michael S. Leapman, Hao G. Nguyen, Matthew R. Cooperberg in Current Oncology Reports (2016)

  10. No Access

    Article

    Long-term follow-up of International Prostate Symptom Score (IPSS) in men following prostate brachytherapy

    To investigate variation in the International Prostate Symptom Score (IPSS) in men following prostate brachytherapy.

    Xuesong Li, Dong Fang, Matthew R. Cooperberg, Jared M. Whitson in World Journal of Urology (2014)

  11. No Access

    Article

    A new look at prostate cancer treatment complications

    A recent population-based analysis from Nam and coauthors found high complication rates occurring within 5 years of prostatectomy or radiation therapy interventions for prostate cancer. These findings emphasiz...

    Matthew R. Cooperberg in Nature Reviews Clinical Oncology (2014)

  12. No Access

    Article

    For localized prostate cancer, does technology equal progress?

    Recent evolution of prostate cancer treatment reflects technological arms races driven by economic incentives rather than high-quality evidence—as exemplified by proton-beam radiation, recently found markedly ...

    Matthew R. Cooperberg in Nature Reviews Clinical Oncology (2012)

  13. Article

    Open Access

    The example of CaPSURE: lessons learned from a national disease registry

    Although randomized controlled trials (RCTs) remain the gold standard for determining evidence-based clinical practices, large disease registries that enroll large numbers of patients have become paramount as ...

    Sima P. Porten, Matthew R. Cooperberg, Badrinath R. Konety in World Journal of Urology (2011)

  14. No Access

    Chapter

    Quality of Care Indicators for Radical Cystectomy

    Radical cystectomy is the gold standard treatment for invasive bladder cancer, and requires high standards for both surgical skill and ancillary support to achieve consistently good outcomes. As is the case el...

    Matthew R. Cooperberg, Badrinath R. Konety in Bladder Cancer (2010)

  15. No Access

    Article

    High-risk prostate cancer in the United States, 1990–2007

    This study aimed to describe national trends in presentation, management, and outcomes for men with high risk prostate cancer.

    Matthew R. Cooperberg, Janet Cowan, Jeannette M. Broering in World Journal of Urology (2008)